Page last updated: 2024-09-02

ecteinascidin 743 and Chondrosarcoma, Mesenchymal

ecteinascidin 743 has been researched along with Chondrosarcoma, Mesenchymal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araki, N; Hiraga, H; Hiruma, T; Horiuchi, K; Kawai, A; Kikuta, K; Kunisada, T; Matsumine, A; Morioka, H; Nakayama, R; Nishimoto, K; Sugiura, H; Susa, M; Takahashi, M; Takahashi, S; Ueda, T; Yonemoto, T1

Trials

1 trial(s) available for ecteinascidin 743 and Chondrosarcoma, Mesenchymal

ArticleYear
Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
    BMC cancer, 2016, 07-14, Volume: 16

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Chondrosarcoma; Chondrosarcoma, Mesenchymal; Dioxoles; Disease-Free Survival; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasms, Connective and Soft Tissue; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome

2016